Research publications

Clinical characteristics and laboratory identification of Aerococcus infections: an Australian tertiary centre perspective

Narayanasamy S, King K, Dennison A, Spelman DW, Aung AK

(2017), Int J Microbiol, 2017, 5684614

DOI: 10.1155/2017/5684614

Clinical effectiveness of early posaconazole suspension pre-emptive therapy in lung transplant recipients: The Alfred's experience

Jeong W, Snell GI, Levvey BJ, Westall GP, Morrissey CO, Ivulich S, Neoh CF, Slavin MA, Kong DCM

(2017), J Antimicrob Chemother, 72(7), 2089-92

DOI: 10.1093/jac/dkx085

Optimizing microplate biofilm assays to screen anti-infective surfaces

Qu Y, Thissen H, McGiffin D, Peleg AY

(2017), Trends Biotechnol, 35(1), 3-5

DOI: 10.1016/j.tibtech.2016.09.001

Listeria monocytogenes peritonitis in an HIV-infected patient

Sia C, Wilson S, Ananda-Rajah M, Mills J, Aung AK

(2017), Clin Nephrol, 87(5), 267-70

DOI: 10.5414/CN108897

Colliding epidemics and the rise of cryptococcosis

Chang CC, Chen SC-A

(2016), J Fungi, 2(1),

Tenofovir therapy for hepatitis B may be commonly prescribed without HIV testing

Deshpande S, Ko T, Roberts E, Lau JS, Horne K, Williams J, Kiss C, Ratnam D, Woolley I

(2016), J Acquir Immune Defic Syndr, 71(2),

Do people with HIV infection have a higher risk of fracture compared with those without HIV infection?

Hoy J, Young B

(2016), Curr Opin HIV AIDS, 11(3),

Isn't it time to talk about antiretroviral stewardship?

Woolley I

(2016), J Chemother, 28(4),

Polymicrobial infections involving clinically relevant Gram-negative bacteria and fungi

Dhamgaye S, Qu Y, Peleg AY

(2016), Cell Microbiol, 18(12),

Enhancing dendritic cell activation and HIV vaccine effectiveness through nanoparticle vaccination

Glass JJ, Kent SJ, De Rose R

(2016), Expert Rev Vaccines, 15(6),

Repeated therapeutic lumbar punctures in cryptococcal meningitis – necessity and/or opportunity?

Chang CC, Perfect JR

(2016), Curr Opin Infect Dis, 29(6),

Immune reconstitution inflammatory syndrome in invasive fungal infections: what we know and what we need to know?

Chang CC, French MA

(2016), Curr Clin Microbiol Rep, 3(2),

Clinically relevant concentrations of fosfomycin combined with polymyxin B, tobramycin or ciprofloxacin enhance bacterial killing of Pseudomonas aeruginosa, but do not suppress the emergence of fosfomycin resistance

Walsh CC, Landersdorfer CB, McIntosh MP, Peleg AY, Hirsch EB, Kirkpatrick CM, Bergen PJ

(2016), J Antimicrob Chemother, 71(8),

Factors associated with discussion of sexual activity and contraception in women with HIV

Stewart ZA, Shipley K, Spelman T, Giles ML

(2016), J Fam Plann Reprod Health Care, 42(1),

Searching for new strategies against polymicrobial biofilm infections: guanylated polymethacrylates kill mixed fungal/bacterial biofilms

Qu Y, Locock K, Verma-Gaur J, Hay ID, Meagher L, Traven A

(2016), J Antimicrob Chemother, 71(2),

CXCR5(+) follicular cytotoxic T cells control viral infection in B cell follicles

Leong YA, Chen Y, Ong HS, Wu D, Man K, Deleage C, Minnich M, Meckiff BJ, Wei Y, Hou Z, Zotos D, Fenix KA, Atnerkar A, Preston S, Chipman JG, Beilman GJ, Allison CC, Sun L, Wang P, Xu J, Toe JG, Lu HK, Tao Y, Palendira U, Dent AL, Landay AL, Pellegrini M,

(2016), Nat Immunol, 17(10),

Rosuvastatin vs. protease inhibitor switching for hypercholesterolaemia: a randomized trial

Lee FJ, Monteiro P, Baker D, Bloch M, Roth N, Finlayson R, Moore R, Hoy J, Martinez E, Carr A

(2016), HIV Med, 17(8),

Impact of a cross-kingdom signaling molecule of Candida albicans on Acinetobacter baumannii physiology

Kostoulias X, Murray GL, Cerqueira GM, Kong JB, Bantun F, Mylonakis E, Khoo CA, Peleg AY

(2016), Antimicrob Agents Chemother, 60(1),

Mucormycosis in Australia: contemporary epidemiology and outcomes

Kennedy KJ, Daveson K, Slavin MA, van Hal SJ, Sorrell TC, Lee A, Marriott DJ, Chapman B, Halliday CL, Hajkowicz K, Athan E, Bak N, Cheong E, Heath CH, Morrissey CO, Kidd S, Beresford R, Blyth C, Korman TM, Robinson JO, Meyer W, Chen SC; Australia and New

(2016), Clin Microbiol Infect, 22(9),

Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2016 recommendations of the International Antiviral Society-USA Panel

Günthard HF, Saag MS, Benson CA, del Rio C, Eron JJ, Gallant JE, Hoy JF, Mugavero MJ, Sax PE, Thompson MA, Gandhi RT, Landovitz RJ, Smith DM, Jacobsen DM, Volberding PA

(2016), JAMA, 316(2),